SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-07-117925
Filing Date
2007-05-17
Accepted
2007-05-17 17:16:52
Documents
4
Period of Report
2007-06-20
Effectiveness Date
2007-05-17

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 681437
2 GRAPHIC g93815g70n87.jpg GRAPHIC 10974
3 GRAPHIC g93815page_1.jpg GRAPHIC 207770
4 GRAPHIC g93815page_2.jpg GRAPHIC 58149
  Complete submission text file 0001193125-07-117925.txt   1064900
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19756 | Film No.: 07862022
SIC: 2836 Biological Products, (No Diagnostic Substances)